Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Malaria parasite can reawaken after years: New vaccine target may block liver infection (opens in a new tab)

medicalxpress.com · 2026-09-24

Short answerEvidenceSource

Short answer

Needs review

Study found.

We found the study, but the claim check did not finish.

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

We found the study behind this story.

We found the study, but couldn't compare the story to it: the study's evidence could not be profiled.

Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

The source study was found, but the study's evidence could not be profiled, so these claims couldn't be checked.

Claim 1 of 6Not checkedUniversity of South Florida researchers discovered a previously unknown vulnerability in Plasmodium vivax.View evidenceHide evidence

As stateda previously unknown vulnerability

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 2 of 6Not checkedThe study identifies a specific site on the parasite that antibodies can target to block P. vivax from invading liver cells, potentially preventing the parasite from establishing the dormant form that allows malaria to return months or even years later.View evidenceHide evidence

As statedmonths or even years later

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 3 of 6Not checkedThe paper, titled 'Targeting a site of vulnerability on circumsporozoite protein inhibits Plasmodium vivax malaria infection,' was published in Immunity.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 4 of 6Not checkedThe article says antibodies targeting the newly identified epitope on circumsporozoite protein can block the parasite from infecting the liver before dormant forms become established.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 5 of 6Not checkedThe researchers say a vaccine based on the discovery remains several years away, but that the feasibility is already established.View evidenceHide evidence

As statedseveral years away

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 6 of 6Not checkedThe discovery came from two research teams that independently converged on the same vulnerable region of the parasite, then joined forces.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Targeting a site of vulnerability on circumsporozoite protein inhibits Plasmodium vivax malaria infection

Immunity · 2026

Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref, Europe PMC, PubMed · 39 candidate papers

Selected

Targeting a site of vulnerability on circumsporozoite protein inhibits Plasmodium vivax malaria infection

Immunity · 2026 · Crossref

Source (opens in a new tab)
Candidate

Author response for "Viral immunity in immunoglobulin products: global immunity debt and autoimmunity in the post pandemic era"

2026 · Crossref

Source (opens in a new tab)

And 33 more candidates considered.